
    
      The study is a prospective, randomized, placebo-controlled trial. Women scheduled for
      endometriosis surgery between 18-50 years of age will be invited to participate in the study.

      Participants with surgically staged endometriosis will be randomized to the metronidazole
      plus routine postoperative care arm or the placebo plus routine postoperative care arm.
      Participants will take study or placebo drug for a total of 14 days.

      Participants will complete surveys at baseline and postoperatively at 6 weeks, 6 months, 1
      year, 2 years, 3 years, 4 years, and 5 years reporting intensity of endometriosis associated
      pain on a visual analog scale, pregnancy outcomes, quality of life, and sexual health.
    
  